In the News
Shire to combine with Baxalta in £22bn deal
Graham Watson
12th January 2016
More merger activity in the pharmaceutical sector as Shire and Baxalta confirm their £22billion merger, creating a giant market leader in the treatment of rare diseases.
You might also like
Diseconomies of Scale
Study Notes
![](https://tutor2u-net.imgix.net/user-photos/gbr_profile.jpg?auto=compress%2Cformat&crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&q=80&w=100)
Horizontal Integration - Pure Gym buys LA Fitness
30th May 2015
Three-O2 Merger Plans Under Scrutiny
5th February 2016
Fitbit acquires Pebble IP as Pebble Closes Down
8th December 2016
![](https://tutor2u-net.imgix.net/user-photos/gbr_profile.jpg?auto=compress%2Cformat&crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&q=80&w=100)
Watersones buys Foyles in bid to counter Amazon threat
7th September 2018
Marginal Cost Examples
Topic Videos
Why is Tesco so profitable?
Study Notes
![](https://tutor2u-net.imgix.net/user-photos/graham-watson.png?auto=compress%2Cformat&crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&q=80&w=100)
Economies of Scale at Papa Johns
15th March 2024